Preferred Label : enoxaparin;

MeSH definition : Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed);

MeSH synonym : enoxaparine;

Wikipedia automatic translation : Enoxaparin sodium;

MeSH hyponym : lovenox; EMT-967; clexane; PK-10,169; EMT-966; PK 10,169; PK10,169; PK-10169; PK 10169; PK10169; EMT 967; EMT967; EMT 966; EMT966;

Wikipedia link : https://en.wikipedia.org/wiki/Enoxaparin sodium;

Is substance : O;

Details


Main resources

You can consult :

Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)

https://www.has-sante.fr/jcms/p_3498568/fr/lovenox-enoxaparine-sodique-traitement-antithrombotique
2024
false
false
false
France
evaluation of the transparency committee
enoxaparin
antithrombotic agents
Treat
During Treatment
No Treatment for Diabetes
Therapy Object
fibrinolytic agents
Treatment Epoch
Treatment
Biomaterial Treatment
On Treatment
Thrombolytic Agent
GDC Treatment Frequency Terminology
Treatment Study
Enoxaparin Sodium
lovenox

---
https://www.has-sante.fr/jcms/p_3490836/fr/enoxaparine-crusia-enoxaparine-sodique-thrombose-veineuse-profonde-tvp-et-embolie-pulmonaire-ep
2024
false
false
false
France
evaluation of the transparency committee
enoxaparin
embolism and thrombosis
pulmonary embolism
Deep Vein Thrombosis
venous thrombosis
pulmonary embolism
Enoxaparin Sodium
Venous Embolism
Pulmonary Embolism
deep vein thrombosis
deep thrombophlebitis, nos
pulmonary embolism

---
https://www.has-sante.fr/jcms/p_3352216/fr/lovenox-enoxaparine-sodique-tvp/ep-chez-les-patients-atteints-d-un-cancer-actif
2022
France
evaluation of the transparency committee
disease
indicators
traction
enoxaparin
has patient
indicators and reagents
cancer
neoplasm, malignant
patients
Cancer
lovenox
neoplasms
indication of

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Inscription_medicaments/Avis_au_ministre/Mai_2021/Noromby_2021_04.pdf
2021
false
false
false
Canada
French
enoxaparin
drug evaluation

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Inscription_medicaments/Avis_au_ministre/Mai_2021/Inclunox_2021_04.pdf
2021
false
false
false
Canada
French
drug evaluation
enoxaparin

---
https://www.has-sante.fr/jcms/p_3181456/fr/enoxaparine-venipharm
2020
false
false
false
France
enoxaparin
biosimilar pharmaceuticals
evaluation of the transparency committee
enoxaparin

---
https://www.has-sante.fr/jcms/p_3181101
2020
France
evaluation of the transparency committee
lovenox
enoxaparin

---
https://www.has-sante.fr/portail/jcms/c_2901469/fr/abenox
2019
false
false
false
France
enoxaparin
biosimilar pharmaceuticals
anticoagulants
fibrinolytic agents
treatment outcome
insurance, health, reimbursement
enoxaparin
venous thromboembolism
postoperative complications
acute disease
venous thrombosis
deep vein thrombosis
pulmonary embolism
clotting in the extracorporeal circuit during haemodialysis
angina, unstable
myocardial infarction
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2860508/fr/inhixa
2018
false
false
false
false
France
French
evaluation of the transparency committee
enoxaparin
enoxaparin

---
https://www.has-sante.fr/portail/jcms/c_2881395/fr/enoxaparine-becat
false
false
false
France
French
enoxaparin
biosimilar pharmaceuticals
injections, subcutaneous
insurance, health, reimbursement
treatment outcome
venous thromboembolism
deep vein thrombosis
pulmonary embolism
renal dialysis
angina, unstable
myocardial infarction
anticoagulants
fibrinolytic agents
surgical procedures, operative
evaluation of the transparency committee
enoxaparin
venous thrombosis

---
https://www.ema.europa.eu/medicines/human/EPAR/thorinane
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
enoxaparin
drug approval
europe
enoxaparin
breast feeding
pregnancy
drug interactions
injections, subcutaneous
injections, intravenous
Prefilled Syringe Dosage Form
biosimilar pharmaceuticals
anticoagulants
anticoagulants
drug therapy, combination
aspirin
angina, unstable
myocardial infarction
venous thromboembolism
postoperative complications
deep vein thrombosis
clotting in the extracorporeal circuit during haemodialysis
catheter obstruction
fibrinolytic agents
fibrinolytic agents
adult
risk assessment
product surveillance, postmarketing
drug evaluation, preclinical
Factor Xa Inhibitors
Factor Xa Inhibitors
enoxaparin
venous thrombosis

---
https://www.minerva-ebp.be/fr/article/183
2012
false
true
false
false
minerva-ebm.be
Belgium
venous thromboembolism
inpatients
enoxaparin
pyrazoles
pyridones
pyrazoles
pyridones
adult
comparative study
critical appraisal or critical reading
apixaban

---
https://www.minerva-ebp.be/fr/article/245
2011
false
true
false
false
minerva-ebm.be
Belgium
enoxaparin
venous thrombosis
Rivaroxaban
critical appraisal or critical reading
venous thrombosis

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Enoxaparin.aspx
http://www.aboutkidshealth.ca/en/healthaz/drugs/pages/enoxaparin.aspx?k=%c3%a9noxaparine;+anticoagulants
2010
Canada
French
English
enoxaparin
child
enoxaparin
injections, subcutaneous
enoxaparin
fibrinolytic agents
fibrinolytic agents
anticoagulants
anticoagulants
drug information
patient education handout

---
https://www.cadth.ca/sites/default/files/pdf/283_ximelagatran_cetap_f.pdf
2004
Canada
French
anticoagulotherapy
azetidines
anticoagulants
venous thrombosis
venous thrombosis
treatment outcome
warfarin
enoxaparin
warfarin
azetidines
enoxaparin
anticoagulants
anticoagulants
azetidines
warfarin
enoxaparin
hemorrhage
risk factors
postoperative complications
risk
clinical trials as topic
benzylamines
benzylamines
benzylamines
ximelagatran
azetidines
benzylamines
evaluation studies
comparative study
table
journal article

---
Nous contacter.
16/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.